Why Zomedica Stock Plunged Today

Joe Tenebruso, The Motley Fool
·2 min read
Why Zomedica Stock Plunged Today

Shares of Zomedica Pharmaceuticals (NYSEMKT: ZOM) fell 13.7% on Thursday after the veterinary health company announced a change to its sales strategy. Zomedica will build out its internal sales team as it transitions away from its current distributor-based approach. CEO Robert Cohen said the move was precipitated by "changes at our current distributor that we believe have impacted its ability to market our products effectively."